These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Prevalence and susceptibility of highly gentamicin resistant Enterococcus faecalis in a south London teaching hospital. Smyth EG; Stevens PJ; Holliman RE J Antimicrob Chemother; 1989 Apr; 23(4):633-9. PubMed ID: 2501271 [TBL] [Abstract][Full Text] [Related]
67. Synergism of cefazolin-gentamicin against enterococci. Bourque M; Quintiliani R; Tilton RC Antimicrob Agents Chemother; 1976 Jul; 10(1):157-63. PubMed ID: 825022 [TBL] [Abstract][Full Text] [Related]
68. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [TBL] [Abstract][Full Text] [Related]
69. Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis. Kim KS; Bayer AS J Antimicrob Chemother; 1987 Apr; 19(4):475-85. PubMed ID: 3108228 [TBL] [Abstract][Full Text] [Related]
70. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Yao JD; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC Antimicrob Agents Chemother; 1990 May; 34(5):827-30. PubMed ID: 2141778 [TBL] [Abstract][Full Text] [Related]
71. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis. Lefort A; Saleh-Mghir A; Garry L; Carbon C; Fantin B Antimicrob Agents Chemother; 2000 Nov; 44(11):3017-21. PubMed ID: 11036016 [TBL] [Abstract][Full Text] [Related]
72. Streptococcus milleri endocarditis complicated by myocardial abscess. Levandowski RA South Med J; 1985 Jul; 78(7):892-3. PubMed ID: 4012392 [TBL] [Abstract][Full Text] [Related]
73. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin]. Martínez F; Martín Luengo F; Valdés M Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022 [TBL] [Abstract][Full Text] [Related]
75. Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis. Kikuchi K; Enari T; Minami S; Haruki K; Shibata Y; Hasegawa H; Katahira J; Totsuka K; Shimizu K J Antimicrob Chemother; 1994 Nov; 34(5):687-96. PubMed ID: 7706164 [TBL] [Abstract][Full Text] [Related]
76. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci. Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865 [TBL] [Abstract][Full Text] [Related]
77. Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline. Sakoulas G; Nonejuie P; Nizet V; Pogliano J; Crum-Cianflone N; Haddad F Antimicrob Agents Chemother; 2013 Aug; 57(8):4042-5. PubMed ID: 23689728 [TBL] [Abstract][Full Text] [Related]
78. The heterogeneity of Streptococcus viridans: therapeutic considerations in infective endocarditis. Fisher J; Levene DL Can Med Assoc J; 1975 May; 112(10):1217-9. PubMed ID: 1125890 [TBL] [Abstract][Full Text] [Related]
79. Prosthetic endocarditis treated with ampicillin and gentamicin in a penicillin-hypersensitive patient. Petheram IS; Boyce JM Br Med J; 1976 Oct; 2(6040):851-2. PubMed ID: 825181 [No Abstract] [Full Text] [Related]
80. [Aminoglycosides in the treatment of infectious endocarditis]. Malinverni R Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]